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Background: To investigate the interfraction displacement and volume variation of primary thoracic esophagus
carcinoma with enhanced four-dimensional computed tomography (4DCT) scanning during fractionated radiotherapy.
Methods: 4DCT data sets were acquired at the time of treatment simulation and every ten fraction for each of 32
patients throughout treatment. Scans were registered to baseline (simulation) 4DCT scans by using bony landmarks.
The gross tumor volumes (GTVs) were delineated on each data set. Coordinates of the GTV centroids were acquired on
each respiration phase. Distance between center of the GTV contour on the simulation scan and the centers on
subsequent scans were used to assess interfraction displacement between fractions. Volumes were constructed using
three approaches: The GTV delineated from the maximum intensity projection (MIP) was defined IGTVMIP, all 10 GTVs
were combined to form IGTV10, GTVmean was the average of all 10 phases of each GTV.
Results: Interfraction displacement in left-right (LR), anterior-posterior (AP), superior-inferior (SI) directions and 3D
vector were 0.13 ± 0.09 cm, 0.16 ± 0.12 cm, 0.34 ± 0.26 cm and 0.43 ± 0.24 cm, respectively between the tenth fraction
and simulation 4DCT scan. 0.14 ± 0.09 cm, 0.19 ± 0.16 cm, 0.45 ± 0.43 cm and 0.56 ± 0.40 cm in LR, AP, SI and 3D vector
respectively between the twentieth fraction and simulation 4DCT scan. Displacement in SI direction was larger than LR
and AP directions during treatment. For distal esophageal cancer, increased interfraction displacements were observed
in SI direction and 3D vector (P = 0.002 and P = 0.001, respectively) during radiotherapy. The volume of GTVmean,
IGTVMIP, and IGTV10 decreased significantly at the twentieth fraction for middle (median: 34.01%, 33.09% and 28.71%,
respectively) and distal (median: 22.76%, 25.27% and 23.96%, respectively) esophageal cancer, but for the upper third,
no significant variation were observed during radiotherapy.
Conclusions: Interfractional displacements in SI direction were larger than LR and AP directions. For distal location,
significant changes were observed in SI direction and 3D vector during radiotherapy. For middle and distal locations,
the best time to reset position should be selected at the twentieth fraction when the primary tumor target volume
changed significantly, and it was preferable to guide target correction and planning modification.
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Age, median, y (range) 71 (45–89)
Tumor histology, n (%)
Squamous cell carcinoma 25 (78.1%)
Adenocarcinoma 7 (19.9%)
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Radiotherapy (RT) plays an important role in the treat-
ment of esophageal cancer, the three-dimensional con-
formal radiotherapy (3D-CRT) and intensity-modulated
radiotherapy (IMRT) are the most important delivery plat-
forms [1,2]. Precise definition of RT fields is crucial for RT
planning. Variation of target volume and displacement
are the sources for RT fields and plan modification, such
changes can be intrafractional or interfractional. Intrafrac-
tional esophageal motion can be attributed mostly to
respiration, cardiac activity, and esophageal peristalsis
[3], which has been well documented [4-8]. But studies
about interfractional esophageal motion were limited.
As a consequence of radiation treatment, tumor volumes
will change during radiotherapy, significant regression in
lung tumor volume can occur by 3 weeks after beginning
treatment [9-11]. But so far, no conclusive data exist as
to the nature of the tumor volume changes during radio-
therapy for primary esophageal cancer, or the time at
which these changes occur.
Relative to three-dimensional computed tomography
(3DCT), four-dimensional computed tomography (4DCT)
scan could not only obtain the volume of primary tumor
GTV without motion information, for example, the GTV
delineated on a single phase; but also obtain internal gross
tumor volume (IGTV) volume with entire motion infor-
mation, for example, the IGTV combined from 10 phases.
In addition, we also can obtain IGTVMIP from the max-
imum intensity projection (MIP). Therefore, based on re-
peated 4DCT, we can obtain more precise variation of
target volume during entire treatment for primary esopha-
geal cancer. In present study, we measured the interfrac-
tional displacement of the GTV, and variation of GTV/
IGTV in conventional fractioned RT during treatment for
primary esophageal cancer using repeated 4DCT.
Methods
Patient characteristics
A total of 32 patients with pathologically confirmed thor-
acic esophageal cancer were considered eligible for
radiotherapy with 3DCRT or IMRT from August 2011
to October 2012. 32 patients completed the simulation
4DCT scan and the tenth fractional scan, 27 patients
completed the twentieth fractional scan. Patients with
poor pulmonary function or preexisting respiratory prob-
lems were excluded. Written informed consent was
obtained from all of the patients before the treatment
was initiated. The patient characteristics are listed in
Table 1.
CT data acquisition
Every patient underwent a 4DCT scan on a 16-slice CT
scanner (Philips Brilliance Bores CT, Netherlands). All of
the patients were scanned in supine position with armsstretched over the head using the vacuum bag, followed
by laser alignment. Metal marks were applied to the
laser cross marked points in the bilateral axial midline
and the anterior midline. Images were obtained from
the neck to the mid-abdomen using the axial CT mode,
and all these scans were gathered during free breathing
(FB) without any breathing control. During the 4DCT
image acquisition, the patient’s respiration was monitored
using the Real-Time Position Management (RPM) Respira-
tory Gating System (Varian Medical Systems, Palo Alto,
CA) by tracking the trajectory of the infrared markers
placed on the patient’s abdomen. The signal was sent to
the scanner to label a time tag on each CT image. GE
Advantage 4D software (GE Healthcare, Waukesha, WI)
sorts the reconstructed 4DCT images into ten respira-
tory phases labeled as 0% - 90% on the basis of these
tags, with 0% corresponding to end inspiration (EI) and
50% corresponding to end expiration (EE). The 4DCT
images were reconstructed using a thickness of 3 mm
and then transferred to the Eclipse treatment planning
system (TPS) (Eclipse 8.6, Varian Medical Systems,
Palo Alto, CA) for structure delineation and treatment
planning generation.
GTV delineation, volume and displacement determination
All of the 4DCT data sets of each patient were registered
to the reference 4DCT scanning (the first 4DCT scan/
simulation) corresponding to the end expiration phase
(respiratory phase 50%, GTV50) using software tools in
the radiation treatment-planning system on the basis of
bony landmarks for comparison. For each 4DCT data
set, the primary tumor (was considered as the GTV) was
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window widths. The full respiration GTV centroid posi-
tions were acquired by the Varian Eclipse 8.6 treatment
planning system. Volumes were constructed using three
approaches: GTVmean was the average of all 10 phases
of each GTV, IGTVMIP was the contour delineated from
the MIP, all 10 GTVs were combined to form IGTV10.
Displacement in each direction between the center of
the GTV50 contour on the simulation scan and the centers
on subsequent scans was used to assess interfraction dis-
placement between fractions, which was obtained by
coordinates of the GTV50 centroid on the subsequent
datasets subtracted that on the reference dataset. In
addition, the three dimensional tumor motion vector was
obtained using motion data in the different axes.Statistical analysis
The displacement among three directions and the dis-
placement in the same direction among different loca-
tions during the same fraction were used by one-way
ANOVA. The displacements on the same direction among
all fractions and volumes among all fractions were used by
a paired sample T test. Values of P < 0.05 were considered
significant. All statistical analyses were performed using
the SPSS software package.Results
Comparison of the interfraction displacement for the
tenth fraction 4DCT scan
For all of the patients, slightly larger displacements were
observed in the SI direction with mean ± standard devi-
ation (SD) of 0.34 ± 0.26 cm, compared with 0.13 ± 0.09 cm
(P = 0.000) and 0.16 ± 0.12 cm (P = 0.001) in the LR and
AP directions, respectively. The mean magnitude of the
interfractional GTV centroid positional variations for the
upper, middle, and distal esophageal cancer were summa-
rized in Table 2. The displacements in the SI direction
were also larger than LR and AP directions (P = 0.024,
P = 0.028; P = 0.049, 0.047; P = 0.000, P = 0.001; respect-
ively). The displacements in the distal location wereTable 2 Magnitude (cm) of interfraction GTV centroid motion
Group LR AP
Range Mean SD Range Mean SD Ran
Upper 0.01-0.35 0.13 0.11 0.01-0.26 0.13 0.09 0.01
Mid- 0.02-0.32 0.14 0.10 0.01-0.46 0.15 0.13 0.01
Distal 0.01-0.17 0.14 0.04 0.08-0.50 0.21 0.13 0.13
F 0.168 0.892
P 0.846 0.421
Abbreviation: GTV gross tumor volume, 4DCT four-dimensional computed tomography
SD standard deviation; “F”, the ratio of mean square about “between groups” and “wi
p values. Values of P < 0.05 were considered significant.larger than in the upper and middle tumor locations
in the SI direction and the 3D vector.
Comparison of the interfraction displacement for the
twentieth fraction 4DCT scan
For all of the patients, displacement in LR, AP, and
SI direction were 0.14 ± 0.09 cm, 0.19 ± 0.16 cm, and
0.45 ± 0.43 cm, respectively. The displacement in SI
direction was larger than LR (P = 0.001) and AP (P = 0.007)
direction. The mean magnitude of the interfractional
GTV centroid positional variations for upper, middle,
and distal esophageal cancer were summarized in Table 3.
The displacements in SI direction were also larger than
in LR and AP directions (P = 0.011, P = 0.028; P = 0.048,
0.045; P = 0.000, P = 0.000; respectively). The displace-
ments in the distal location were larger than in the
upper and middle location in the AP, SI direction and
the 3D vector.
Changes of interfraction displacement of the GTV
centroid during treatment
For the upper and middle tumor locations, no significant
differences were found in each direction and the 3D vec-
tor. For the distal esophageal cancer, significant differ-
ences were observed in SI direction and the 3D vector
(P = 0.002 and P = 0.001, respectively) during radiotherapy.
Variation of tumor volumes
The tumor volumes variation of the GTVmean, the
IGTVMIP and the IGTV10 during radiotherapy are listed
in Table 4. The tumor volume showed a trend of decline
during the entire treatment, the change trend of GTVmean,
IGTVMIP, and IGTV10 are completely consistent. At the
tenth fraction, the volume of GTVmean, IGTVMIP, and
IGTV10 decreased, but the variations are not significant
compared to primary volumes for the upper, middle
and distal tumor locations. For the GTVmean, volumes
are increased 22.41% in 7 of 32 patients (range, 4.20%-
39.42%), differences are statistically significant (P = 0.003).
At the twentieth fraction, tumor volumes shrink further
more, for all of the tumors, the volume of GTVmean,for the tenth fraction 4DCT scan
SI F P 3D vector
ge Mean SD Range Mean SD
-0.65 0.31 0.25 3.745 0.038 0.03-0.78 0.39 0.23
-0.75 0.33 0.23 3.806 0.034 0.05-0.77 0.41 0.23
-0.87 0.51 0.25 13.672 0.000 0.25-0.89 0.59 0.22
3.681 3.251
0.038 0.048
, LR right–left, AP anterior–posterior, SI superior–inferior, 3D three-dimensional,
thin groups” used by one-way ANOVA; “P” , the significance based on two-tailed
Table 3 Magnitude (cm) of interfraction GTV centroid motion for the twentieth fraction 4DCT scan
Group LR AP SI F P 3D vector
Range Mean SD Range Mean SD Range Mean SD Range Mean SD
Upper 0.04-0.14 0.08 0.04 0.01-0.39 0.13 0.13 0.09-1.30 0.40 0.39 4.405 0.023 0.12-1.30 0.46 0.38
Mid- 0.02-0.34 0.14 0.10 0.01-0.41 0.16 0.14 0.01-0.55 0.37 0.20 3.614 0.041 0.02-0.58 0.42 0.17
Distal 0.01-0.54 0.16 0.10 0.01-0.54 0.31 0.16 0.45-1.66 0.86 0.39 17.919 0.000 0.54-1.67 0.96 0.36
F 3.132 3.565 10.055 9.318
P 0.062 0.044 0.001 0.001
Abbreviation: GTV gross tumor volume, 4DCT four-dimensional computed tomography, LR right–left, AP anterior–posterior, SI superior–inferior, 3D three-dimensional,
SD standard deviation. “F”, the ratio of mean square about “between groups” and “within groups” used by one-way ANOVA; “P” , the significance based on two-tailed
p values. Values of P < 0.05 were considered significant.
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to those of primary volumes (P = 0.000, P = 0.000 and
P = 0.000, respectively). For the middle location, the
GTVmean volume decreased 34.01% (range, 13.45%-63.28%,
P = 0.009), IGTVMIP 33.09% (range, 6.00%-58.00%, P =
0.007), IGTV10 28.71% (range, 2.00%-54.00%, P = 0.012).
For the distal esophageal cancer, GTVmean volume de-
creased 22.76% (range, 14.01%-50.64%, P = 0.047), IGTVMIP
25.27% (range, 9.00%-48.00%, P = 0.024), IGTV10 23.96%
(range, 11.00%-51.00%, P = 0.029). But for the upper loca-
tion, no significant reduction to the volume of GTVmean,
IGTVMIP, and IGTV10 (P = 0.079, P = 0.082, and P = 0.164,
respectively). Figure 1 showed the absolute volumetric
changes of the GTVmean during 3DCRT/IMRT.
Discussion
The accurate definition of a target is crucial for the
delivery of high-precision radiotherapy in esophageal
cancer. The planning target volume (PTV) is defined
as the clinical target volume plus an internal margin
(IM) that includes the target internal motion and daily
setup error (SM) [12]. Some researchers have reported
that the tumor position varies intrafractionally, but
interfractional displacement and tumor volume variation
during radiotherapy were limited. The aim of this study
was to introduce interfraction displacement and regres-
sion of tumor volume over entire treatment for primary
esophageal cancer.
Interfractional displacement is defined as displace-
ment of the tumor position relative to its position atTable 4 Variation of tumor volume during radiotherapy(cm3,
Group GTVmean I
Simulation Tenth Twentieth Simulation
Upper 14.82 ± 10.22 12.15 ± 7.15 11.24 ± 10.17 15.5 ± 10.00 12
Mid- 33.63 ± 17.15 29.63 ± 17.39 24.21 ± 13.25 35.18 ± 18.29 31.1
Distal 22.04 ± 8.67 20.92 ± 8.69 17.69 ± 7.43 23.10 ± 8.67 21
Total 25.08 ± 15.53 22.35 ± 14.59 17.95 ± 11.75 26.25 ± 16.07 23.6
Abbreviation: GTV gross tumor volume, IGTV internal gross tumor volume, MIP maxim
4DCT scan, twentieth the twentieth 4DCT scan.simulation between fractions, reports of which have been
limited. In this study, we analyzed interfraction displace-
ment not only in whole esophagus but also in upper,
middle, and distal esophagus. In addition, we compared
the displacement on same direction among different lo-
cations, and the displacement on same direction over
entire treatment.
In the present study, interfractional displacement in
the SI direction is larger than LR and AP direction
whether for whole esophagus or different locations dur-
ing entire course of treatment (Table 2 and Table 3).
These results are consistent with the reported data from
Wang et al. [13], who used 4DCT to analyze interfractional
displacement for 22 esophageal malignancy patients at
the end expiration phase. They demonstrated that the
interfractional displacement of the gastroesophageal
junction (GEJ) in the SI, AP, and LR directions were
6.77 mm (maximum displacement, 17.6 mm), 2.90 mm
and 2.88 mm, respectively. They also confirmed that the
interfractional systematic displacement in the SI direc-
tion correlated strongly with the interfractional change
in tidal volume (r = 0.9635) and vertical diaphragmatic
displacement (r =0.9437). Perhaps this is the reason why
displacement in the SI direction is larger than in the LR
and AP direction. Cohen et al. [14] used CT-on-rails to
study 8 patients with esophageal tumors and found a
mean absolute esophageal displacement of 3.2 mm below
and 4.2 mm above the carina in the LR direction and a
mean absolute AP displacement of 2.8 mm posterior
below and 3.9 mm posterior above the carina. Anothermean ± SD,)
GTVMIP IGTV10
Tenth Twentieth Simulation Tenth Twentieth
.84 ± 7.61 11.84 ± 10.37 19.95 ± 14.30 16.44 ± 10.44 16.89 ± 18.41
6 ± 18.22 25.33 ± 13.90 42.40 ± 21.18 37.86 ± 21.46 31.69 ± 16.49
.96 ± 9.18 18.70 ± 7.81 29.68 ± 11.09 27.90 ± 12.57 23.98 ± 10.40
2 ± 15.33 18.87 ± 12.23 32.51 ± 19.10 28.88 ± 18.30 24.47 ± 16.36
um intensity projection, simulation the simulation 4DCT scan, tenth the tenth
Figure 1 Absolute volumetric changes of GTVmean during 3DCRT/IMRT (n = 32).
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shifts in 20 patients with esophageal cancer showed
similar 5 mm in the LR direction and 5 mm in the AP
direction. However, the two studies above did not ad-
dress interfractional esophageal motion in the SI direc-
tion. The study from Wang et al. [13] did include the SI
direction, but they limited their study to the GEJ and
did not divide the esophagus into different segments.
In our study, we found displacement in the SI direc-
tion and 3D vector in the distal location were larger than
upper and middle third esophagus during radiotherapy.
This finding suggests that displacement in the distal
esophagus is large, especially in the SI direction. Wang’s
study [13] also found large interfractional SI displace-
ments. We also analyzed displacement variation on the
same direction over entire treatment. For the upper and
middle locations, no significant differences were foundin each direction and 3D vector. For the distal esopha-
geal cancer, significant differences were observed in the
SI direction and 3D vector (P = 0.002 and P = 0.001, re-
spectively) during radiotherapy. Along with treatment,
the displacement in SI direction (0.86 ± 0.39 cm vs
0.51 ± 0.25 cm) and 3D vector (0.96 ± 0.36 cm vs 0.59 ±
0.22 cm) for distal patients increased. Suggesting that
expanding margin reasonably in SI direction is needed
for the distal patients at the twentieth fraction. Wang
et al. [13] analyzed one patient who had the largest infer-
ior systematic displacement; the CTV was underdosed,
which resulted in higher-than-expected doses to the GEJ,
and these hot spots also affected exposure to the normal
stomach and lung. Their findings thus justified at least a
10 mm inferior PTV margin. This reminds us that we
must pay great attention to interfractional displacement
at the twentieth fraction, particularly for distal patients,
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and an insufficient dose to the target.
Monitoring the regression and deformation for tumor
volume could help revise the target and treatment plan
in time. In this study, we found the majority of the
tumor volumes were decreased with increasing fractions
during radiotherapy based on repeated 4DCT scanning.
However, at the tenth fraction, the volume of the GTVmean
increased 22.41% in 7 of 32 patients (range, 4.20%-39.42%).
Similar to our study, Britton et al. [10] used 4DCT to
assess GTV regression during radiotherapy for non-small-
cell lung cancer; they showed a transient increased in the
GTV volume for 5 patients during the first or second
week of treatment. The case was also observed in intracra-
nial lesions [16-22]. In the process of sketch, we found
that the tumor and esophageal mucosa nearby thickened
locally, but by only relying on CT imaging, we cannot
judge whether the increase is caused by oedema or infil-
tration. Therefore, according to the studies above, clini-
cians should pay attention to tumor volume change at
the initial treatment, because target mispositioning will
result in a high radiation dose to the normal tissues and
an insufficient dose to the target.
Along with the progress of radiotherapy treatment, the
tumor size decreased significantly. In our study, except
for upper third esophagus, the GTVmean, IGTVMIP, and
IGTV10 of middle and distal esophageal cancer decreased
significantly at the twentieth fraction. Studies on lung
cancer concluded that significant changes in the target
volume occurred after 2 weeks. For example, A study
from Underberg et al. [23], who identify potential time
trends in target volumes and tumor mobility after stereo-
tactic radiotherapy (SRT) for Stage I non–small-cell lung
cancer in 40 tumors, showed that GTV and ITV de-
creased significantly at the fourth week after the start of
treatment (P < 0.015). In our study, we found the larger
the absolute initial tumor volume, the greater the abso-
lute tumor volume shrinking. In the present study, the
tumor volume in the upper third is smaller than that
of mid- and distal segment (P = 0.003), perhaps this is
the reason to the differentiation of volume change in
different locations. Our study showed that the tumor
volume in 2 patients increased continuously over entire
course of treatment. We analyzed the probable causes
may be related to image artifacts affecting the numbers
of slices contoured. We could not rule out the cause of
the tumor growth.
In addition, a similar time trend as for the GTVmean
was observed for the IGTV10 and IGTVMIP, with an
overall decrease during radiotherapy. Just as the GTVmean,
the volumes also decreased significantly at the twentieth
fraction. IGTV10 was fused by GTVs on ten phases,
contained mobility information of entire respiratory cycle
[24,25]. Our results show that the GTV or IGTV volumechanges significantly at the twentieth fraction of treat-
ment, suggesting the need for reimaging and potential
replanning for some patients.
Conclusions
We investigated the interfraction displacement and tumor
volume variation during radiotherapy for primary esopha-
geal cancer. Larger displacement in SI direction was ob-
served, significant variation were exist in SI direction
and 3D vector for distal esophageal cancer during radio-
therapy. Tumor volume decreased significantly at the
twentieth fraction. Therefore, for primary middle and
distal esophageal cancer, the best time to reset the pos-
ition may be at the twentieth fraction when the primary
tumor target volume changed significantly. Resetting the
position is recommended to guide the target correction
and treatment planning modification.
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